Recombinant growth hormone in children and adolescents with Turner syndrome.

  • Cave C
  • Bryant J
  • Milne R
  • 3


    Mendeley users who have this article in their library.
  • 21


    Citations of this article.


Turner syndrome (TS) affects about one in 1,500 to 2,500 live-born females. One of the most prevalent and salient features of the syndrome is extremely short stature. Untreated women are approximately 20-21 cm shorter than normal women within their respective populations. Recombinant human growth hormone (hGH) has been used to increase growth and final height in women who have Turner syndrome.

Author-supplied keywords

  • Adolescent
  • Body Height
  • Child
  • Female
  • Growth Disorders
  • Growth Disorders: drug therapy
  • Growth Disorders: etiology
  • Growth Hormone
  • Growth Hormone: therapeutic use
  • Humans
  • Randomized Controlled Trials as Topic
  • Recombinant Proteins
  • Recombinant Proteins: therapeutic use
  • Turner Syndrome
  • Turner Syndrome: complications

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • C B Cave

  • J Bryant

  • R Milne

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free